Prognostic Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Radiation Therapy

被引:0
|
作者
Kumar, S. [1 ]
Movsas, B. [1 ]
Brown, S. L. [1 ]
Simoff, M. [1 ]
Stone, C. H. [1 ]
Jenrow, K. A. [1 ]
Lapanowski, K. [1 ]
Ajlouni, M. [1 ]
Chetty, I. J. [1 ]
Movsas, A. [2 ]
Lu, M. [1 ]
Sitarik, A. [1 ]
Lamerato, L. [1 ]
Jones, M. R. [3 ]
Hammoud, Z. [1 ]
Peshkin, N. [1 ]
Roszka, K. [1 ]
Parry, R. [4 ]
机构
[1] Henry Ford Hlth Syst, Detroit, MI USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Oakland Univ, Rochester, MI 48063 USA
[4] Varian Med Syst, San Francisco, CA USA
关键词
D O I
10.1016/j.ijrobp.2014.05.1924
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3116
引用
收藏
页码:S650 / S651
页数:2
相关论文
共 50 条
  • [11] Radiation therapy in patients with non-small cell lung cancer and interstitial lung abnormalities
    Ito, M.
    Katano, T.
    Okada, H.
    Sakuragi, A.
    Minami, Y.
    Abe, S.
    Adachi, S.
    Oshima, Y.
    Kubo, A.
    Fukui, T.
    Ito, S.
    Suzuki, K.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1073 - S1074
  • [12] Novel Imaging Biomarkers in Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy
    Aguilera, T. A.
    Daniel, G. I.
    Shultz, D. B.
    Trakul, N.
    Maxim, P. G.
    Rubin, D. L.
    Loo, B. W.
    Diehn, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S546 - S546
  • [13] Anemia is a Significant Prognostic Factor in Overall Survival of Patients with Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
    Tanaka, H.
    Ono, T.
    Takano, H.
    Manabe, Y.
    Kajima, M.
    Shiinoki, T.
    Yamaji, Y.
    Matsunaga, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E152 - E153
  • [14] Anemia is a Prognostic Factor for Overall Survival Rate in Patients with Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
    Tanaka, Hidekazu
    Ono, Taiki
    Manabe, Yuki
    Kajima, Miki
    Fujimoto, Koya
    Yuasa, Yuki
    Shiinoki, Takehiro
    Yamaji, Yoshikazu
    Matsunaga, Kazuto
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7447 - 7453
  • [15] Monocyte-to-lymphocyte ratio is a prognostic predictor for patients with non-small cell lung cancer treated with stereotactic body radiation therapy
    Tanaka, Hidekazu
    Ono, Taiki
    Kajima, Miki
    Manabe, Yuki
    Fujimoto, Koya
    Yuasa, Yuki
    Shiinoki, Takehiro
    Matsuo, Masayuki
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2024, 29 (02) : 228 - 235
  • [16] Prognostic factors for the survival of surgically treated patients for non-small cell lung cancer
    Fernandes, OJCB
    Almgren, SO
    Thaning, L
    Filbey, D
    Helsing, M
    Karlsson, M
    Magnusson, A
    Souza, D
    ACTA ONCOLOGICA, 2003, 42 (04) : 338 - 341
  • [17] Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer
    Kazandjian, Dickran
    Gong, Yutao
    Keegan, Patricia
    Pazdur, Richard
    Blumenthal, Gideon M.
    JAMA ONCOLOGY, 2019, 5 (10) : 1481 - 1485
  • [18] Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
    Rocco, Danilo
    Della Gravara, Luigi
    Ragone, Angela
    Sapio, Luigi
    Naviglio, Silvio
    Gridelli, Cesare
    CANCERS, 2023, 15 (19)
  • [19] Proteomic biomarkers of non-small cell lung cancer patients
    Baran, Kamila
    Brzezianska-Lasota, Ewa
    ADVANCES IN RESPIRATORY MEDICINE, 2021, 89 (04) : 419 - 426
  • [20] Soluble Biomarkers with Prognostic and Predictive Value in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy
    Honrubia-Peris, Beatriz
    Garde-Noguera, Javier
    Garcia-Sanchez, Jose
    Piera-Molons, Nuria
    Llombart-Cussac, Antonio
    Fernandez-Murga, Maria Leonor
    CANCERS, 2021, 13 (17)